 Ontario can limit pharmacy-brand drugs, Supreme Court rules The Supreme Court has dismissed an appeal by Shoppers Drug Mart and the Katz Group, owner of Rexall and Pharma Plus pharmacies, which had argued that the province of Ontario couldn't stop them from selling their own cheaper versions of popular geneCommentsview comments in forum Page 1 You need to be a member of CKA and be logged into the site, to comment on news. |
Share
|
Mobile
All logos and trademarks in this site are property of their respective owner.
The comments are property of their posters, all the rest © 2025 by Canadaka.net
The comments are property of their posters, all the rest © 2025 by Canadaka.net
"Ontario is one of the largest purchasers of prescription drugs in the world and spends about $4.3 billion a year on its provincial prescription drug plan."
The government is gloating over savings by fixing generic drug costs based on a max of 18-25% of the brand price, which all totaled represent only about 3% of the $4.3 billion. The majority of the $500 million saved last year was based on the cheaper generics being introduced into the market rather than the reduction of their cost. With their politically driven claims of a savings victory, they have effectively driven nearly all generic manufacturing out of north America and have limited the introduction of new cheaper generics drugs.
Huge win for the brand companies of the world.